Back to top
more

PDI INC (PDII)

(Delayed Data from NSDQ)

$0.53 USD

0.53
52,373

-0.02 (-3.58%)

Updated Dec 22, 2015 03:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

NA

Industry: NA

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Brokerage Reports

0 items in cart

Interpace Biosciences, Inc. [PDII]

Reports for Purchase

Showing records 1 - 20 ( 42 total )

Company: Interpace Biosciences, Inc.

Industry: Business - Services

Record: 1

11/24/2015

Company Report

Pages: 4

Transferring Coverage

Provider: Roth Capital Partners, Inc.

Price: 10.00

Research Provided by a Third Party

Company: Interpace Biosciences, Inc.

Industry: Business - Services

Record: 2

11/16/2015

Daily Note

Pages: 4

MORNING SUMMARY

Provider: Roth Capital Partners, Inc.

Price: 10.00

Research Provided by a Third Party

Company: Interpace Biosciences, Inc.

Industry: Business - Services

Record: 3

11/13/2015

Company Report

Pages: 4

We are transferring coverage of PDII to Debjit Chattopadhyay, Ph.D. from Scott Henry, CFA to better align coverage universe with research specialty

Provider: Roth Capital Partners, Inc.

Analyst: CHATTOPADHYAY D

Price: 10.00

Research Provided by a Third Party

Company: Interpace Biosciences, Inc.

Industry: Business - Services

Record: 4

08/25/2015

Daily Note

Pages: 3

MORNING SUMMARY

Provider: Roth Capital Partners, Inc.

Price: 10.00

Research Provided by a Third Party

Company: Interpace Biosciences, Inc.

Industry: Business - Services

Record: 5

08/24/2015

Company Report

Pages: 6

Updated Model - Momentum Should Increase in 2H15

Provider: Roth Capital Partners, Inc.

Analyst: HENRY S

Price: 25.00

Research Provided by a Third Party

Company: Interpace Biosciences, Inc.

Industry: Business - Services

Record: 6

07/02/2015

Company Report

Pages: 6

Updated Model - Molecular Diagnostics the Key

Provider: Roth Capital Partners, Inc.

Analyst: HENRY S

Price: 25.00

Research Provided by a Third Party

Company: Interpace Biosciences, Inc.

Industry: Business - Services

Record: 7

07/02/2015

Daily Note

Pages: 3

MORNING SUMMARY

Provider: Roth Capital Partners, Inc.

Price: 10.00

Research Provided by a Third Party

Company: Interpace Biosciences, Inc.

Industry: Business - Services

Record: 8

03/05/2015

Daily Note

Pages: 4

MORNING SUMMARY

Provider: Roth Capital Partners, Inc.

Price: 10.00

Research Provided by a Third Party

Company: Interpace Biosciences, Inc.

Industry: Business - Services

Record: 9

03/04/2015

Company Report

Pages: 7

4Q14 Recap - Time to Deliver on Molecular Diagnostics

Provider: Roth Capital Partners, Inc.

Analyst: HENRY S

Price: 25.00

Research Provided by a Third Party

Company: Interpace Biosciences, Inc.

Industry: Business - Services

Record: 10

11/06/2014

Company Report

Pages: 7

3Q14 Recap - All in on Molecular Diagnostics

Provider: Roth Capital Partners, Inc.

Analyst: HENRY S

Price: 25.00

Research Provided by a Third Party

Company: Interpace Biosciences, Inc.

Industry: Business - Services

Record: 11

11/06/2014

Daily Note

Pages: 6

MORNING SUMMARY

Provider: Roth Capital Partners, Inc.

Price: 25.00

Research Provided by a Third Party

Company: Interpace Biosciences, Inc.

Industry: Business - Services

Record: 12

10/29/2014

Industry Report

Pages: 15

Weekly Small-Cap Technology Round Up

Provider: H.C. WAINWRIGHT & CO., INC.

Price: 50.00

Research Provided by a Third Party

Company: Interpace Biosciences, Inc.

Industry: Business - Services

Record: 13

08/15/2014

Daily Note

Pages: 4

MORNING SUMMARY

Provider: Roth Capital Partners, Inc.

Price: 10.00

Research Provided by a Third Party

Company: Interpace Biosciences, Inc.

Industry: Business - Services

Record: 14

08/15/2014

Company Report

Pages: 7

2Q14 Recap - Molecular Diagnostics is the Key

Provider: Roth Capital Partners, Inc.

Analyst: HENRY S

Price: 25.00

Research Provided by a Third Party

Company: Interpace Biosciences, Inc.

Industry: Business - Services

Record: 15

05/13/2014

Daily Note

Pages: 3

MID-DAY SUMMARY

Provider: Roth Capital Partners, Inc.

Price: 10.00

Research Provided by a Third Party

Company: Interpace Biosciences, Inc.

Industry: Business - Services

Record: 16

05/13/2014

Company Report

Pages: 7

1Q14 Recap - Painful, but Risk/Reward Still Favorable

Provider: Roth Capital Partners, Inc.

Analyst: HENRY S

Price: 25.00

Research Provided by a Third Party

Company: Interpace Biosciences, Inc.

Industry: Business - Services

Record: 17

03/04/2014

Daily Note

Pages: 3

MID-DAY SUMMARY

Provider: Roth Capital Partners, Inc.

Price: 10.00

Research Provided by a Third Party

Company: Interpace Biosciences, Inc.

Industry: Business - Services

Record: 18

03/04/2014

Daily Note

Pages: 3

MID-DAY SUMMARY

Provider: Roth Capital Partners, Inc.

Price: 10.00

Research Provided by a Third Party

Company: Interpace Biosciences, Inc.

Industry: Business - Services

Record: 19

03/04/2014

Company Report

Pages: 7

4Q13 Recap - Lackluster Performance, But Expectations Are Low

Provider: Roth Capital Partners, Inc.

Analyst: HENRY S

Price: 25.00

Research Provided by a Third Party

Company: Interpace Biosciences, Inc.

Industry: Business - Services

Record: 20

02/26/2014

Daily Note

Pages: 3

MID-DAY SUMMARY

Provider: Roth Capital Partners, Inc.

Price: 10.00

Research Provided by a Third Party
// eof